SIRT6 and neoplasm: In summary, these findings illustrate the dual nature of SIRT6 in pancreatic cancer: acting as a promoter of metastasis and chemoresistance in some contexts, while functioning as a suppressor of EMT, glycolysis, and tumor progression in others.